Amgen Shows Confidence in Advaxis’ Platform with $540 M Deal
By Dan Roberts
Pharma Deals Review: Vol 2016 Issue 8 (Table of Contents)
Published: 11 Aug-2016
DOI: 10.3833/pdr.v2016.i8.2183 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Advaxis has recently announced an agreement with Amgen for the development and commercialisation of its preclinical asset ADXS-NEO (Deal no...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS